Hepatitis C Treatment Guide

The treatment regimen includes –

• Evaluation of viral count
• Testing for co-infections
• Evaluation of liver damage

It is then followed by an antiviral regimen and supportive therapies.

The direct-acting antivirals are well tolerated.

These cure 98% of infections.

What is the newest Hepatitis C treatment?

The Direct-Acting Antivirals –

These are the antiviral drugs that target the proteins /enzyme in the virus.

These inhibit the virus life cycle.

The varied class of antivirals is combined to provide an effective cure.

The drug combinations lead to 95 % virus elimination. 

• Prevents drug resistance- 

Hepatitis C is attacked at different sites.

It reduces the probability of viral mutation.

• Provides absolute blockage-

It blocks the cell cycle at multiple points.

• Higher efficacy- 

The combination therapy offers lower side effects and high cure rates.

The commonly used Hepatitis C combinations include – 

• Velakast- Sofosbuvir /Velpatasavir 400mg/100 mg
• Sofokast Plus- Daclatasvir and Sofosbuvir 60/400mg
• Sofokast- Sofosbuvir Tablets 400 mg
• Dacikast- Daclatasvir Tablets 60 mg
• Ribasure- Ribavirin Capsules 200mg
• Ledikast- Ledipasvir & Sofosbuvir Tablets

Is Hepatitis C curable?

Hepatitis C is cured by the daily oral regimen of DAAs.

These drugs inhibit the multiplication /replication of HCV.

The direct-acting antiviral combinations offer successful cure rates.

Does curing Hepatitis C once make you immune for the rest of your life?

The antivirals completely cure Hepatitis C.

It does not provide future protection.

The hepatitis C virus undergoes innumerable mutations.

The body does not produce protective antibodies against all genotypes.

The long-term hepatitis also leads to immune scarring.

The original virus may not return, but the body may interact with a new strain.

Which is the pan-genotypic Hepatitis C combination used globally?

Velakast (Sofosbuvir/Velpatasvir) manufactured by Aprazer Healthcare.

It is a fixed-dose combination containing –

• Sofosbuvir – 400 mg
• Velpatasvir – 100mg

It is a highly prescribed antiviral combination used in Hepatitis C treatment.

Beyond a comprehensive treatment, Velakast offers an affordable treatment regimen.

Benefits of Velakast (Sofosbuvir/Velpatasvir) 

• It is effective against all 6 strains of Hepatitis C.
• It can be used in children aged 3 years or older.
• It is safe to be used in advanced liver disorders.
• Easy dosing – Once daily pill for 12 weeks

Which is the top Hepatitis C medicine manufacturer and global exporter? 

Aprazer Healthcare (hepatology medicine manufacturer) is a top hepatitis C medicine manufacturer.

We are the largest drug exporter from India, manufacturing global-quality antivirals.

As a leading Pharma third-party manufacturer in India- Aprazer Healthcare manufactures a diverse range of generic and branded drugs.

Aprazer Healthcare is a trusted brand in the global markets.